Search Within

Genitourinary Oncology Service

  1. "Robert Motzer"
Formats
  1. Journal Article (610)
  2. Meeting Abstract (580)
  3. Book Section (20)
  4. Review (13)
  5. Correspondence (7)
  6. Conference Paper (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (4)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1252)
  2. Solid Tumor Oncology Division (1252)
  3. Surgery (292)
  4. Urology (283)
  5. Survivorship Research (254)
  6. Department of Pathology and Laboratory Medicine (174)

More Groups

People
  1. Robert Motzer (1252)
  2. George Bosl (182)
  3. Martin Voss (178)
  4. Darren Feldman (158)
  5. Dean Bajorin (128)
  6. Paul Russo (119)

More People

Years
  1. 2025 (35)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (448)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (451)
  2. Oxford University Press (112)
  3. Elsevier Science, Inc. (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (87)
  6. American Association for Cancer Research (58)

More Publishers

Results (1252)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: A retrospective case series
    Journal Article

    Nykaza, I.; Moy, A.; Dusza, S. W.; Moskowitz, A.; Iyer, G.; Iqbal, A.; Motzer, R.; Ilson, D. H.; O'Cearbhaill, R. E.; Kazi, R.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Sensitive HLA-independent T cell receptors overcome tumor antigen heterogeneity in solid tumors
    Meeting Abstract

    Hanina, S.; Park, T.; Lopez, M.; Rajasekhar, V.; Mansilla-Soto, J.; Haubner, S.; Zhao, H.; Banerjee, P.; Koche, R.; Hamard, P. J.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • Impact of tumor burden at progression and changes in risk scores from baseline in patients with advanced renal cell carcinoma treated with lenvatinib + pembrolizumab: Phase 3 CLEAR trial
    Meeting Abstract

    Grünwald, V.; Keizman, D.; Bedke, J.; Staehler, M. D.; Matveev, V. B.; George, S.; Hutson, T. E.; Vaishampayan, U. N.; Merchan, J. R.; Eto, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Biomarkers for renal cell carcinoma — A pragmatic approach
    Editorial

    Bakouny, Z.; Hakimi, A. A.; Reznik, E.; Motzer, R. J.
    Nature Reviews Urology (2025)

    Fulltext@MSK | Save
  • Re: Justine Panian, Caiwei Zhong, Sharon H. Choi, et al. Efficacy of treatments after lenvatinib in patients with advanced renal cell carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.11.011
    Correspondence

    Grünwald, V.; Powles, T.; Hutson, T. E.; Bedke, J.; Porta, C.; Motzer, R. J.
    European Urology Focus (2025)

    Fulltext@MSK | Save
  • Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research
    Meeting Abstract

    Bakouny, Z.; Ahmed, N.; Fong, C.; Rahman, A.; Perea-Chamblee, T.; Pichotta, K.; Waters, M.; Fu, C.; Jeng, M. Y.; Lee, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy of second line (2L) treatment with tivozanib (Tivo) as monotherapy or with nivolumab (Nivo) in patients (pts) with metastatic renal cell carcinoma (mRCC) previously treated with an immune checkpoint inhibitor (ICI) combination of ipilimumab (Ipi)/Nivo or vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI)/ICI in the phase 3 TiNivo-2 study
    Meeting Abstract

    Chehrazi-Raffle, A.; Motzer, Robert J.; Beckermann, K.; Barthelemy, P.; Iacovelli, R.; Emambux, S.; Molina Cerrillomd, J.; Garmezy, B.; Barata, P. C.; McKay, R. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clear and non-clear cell renal cell carcinomas and the ability to engage in oxidative phosphorylation
    Meeting Abstract

    Bakouny, Z.; Boscenco, S.; Cui, R.; Ryu, K.; Kotecha, R. R.; Carlo, M.; Voss, M. H.; Hakimi, A. A.; Motzer, R. J.; Gammage, P. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
    Journal Article

    Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save